Management Team - Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Management Team

World-class scientific team, management team, and advisory board

Segra management consists of an extremely well-rounded group of academics, growers/breeders, sales and marketing specialists, and financial executives. The company’s Advisory Board includes leading experts in the areas of clinical research, plant science, analytical chemistry, marketing, business, and engineering.

Todd McMurray

CEO, President, Director

Mr. McMurray has been the President of Segra Biogenesis for 4 years and CEO of Segra International since its inception 1.5 years ago.  He is a business and corporate development professional with over 26 years of experience planning and financing the strategic initiatives of public and private companies including 4.5 years of experience in the cannabis industry. His background includes over 20 years as a director and/or senior officer of Canadian listed companies.

Zhe Choo

CPA, CA, Chief Financial Officer

Ms. Choo joined Segra in July 2018 with 13 years of progressive public accounting and finance experience. Ms. Choo began her career in the Audit and Assurance Group at PricewaterhouseCoopers LLP and then went on to become a Senior Manager at Ernst & Young LLP where she provided accounting services and advice to numerous clients on various complex accounting transactions. Prior to joining Segra, Ms. Choo worked at a space technology company and was involved in a US$2.4 billion acquisition and integrating the acquired entity.

Dr. Sma Zobayed

Ph.D., Director of Tissue Culture

Dr. Zobayed is a leading specialist in tissue culturing with extensive international experience. Dr. Zobayed holds two patents relating to tissue culturing and has published over 50 scientific papers related to his research in the field. He holds a Ph.D. in Plant Tissue Culture, from the Department of Biological Sciences, University of Hull (UK), and has won awards for his tissue culture work from the scientific community. He is a member in good standing with the International Society of Arboriculture, International Association for Plant Tissue Culture and the International Society for Horticultural Sciences.

Ian Davidson

Chief Business Development Officer

Ian Davidson is a farmer, entrepreneur, and agricultural visionary who has dedicated his entire professional career to building new companies focused on sustainable agricultural production, marketing, and distribution. Ian’s experience in the cannabis space spans more than 15 years, having founded two successful cannabis-focused companies in California. In 2007, Ian founded Biologic Crop Solutions LLC, a landmark wholesale farm supply company providing products and services to over 500 commercial cannabis operations globally. Under Ian’s leadership BCS has established itself as an industry authority on best practices and sustainability for cannabis cultivation. In 2015, Ian founded the agricultural consulting company Davidson Organics, where he developed over 600,000 square feet of high-tech greenhouse cannabis production in California. From 2012-2015, Ian served as the Agronomy Manager for Biological Capital LLC, located on the Hawaiian island of Maui, where he managed agricultural operations at the historic 4000acre Hana Ranch and OW Farm (Oprah Winfrey.) 

Jerry Keiran

Executive Chairman

Mr. Kieran specializes in business development, strategic pricing, and go-to-market strategies in the Commercial Agriculture and cannabis industries. As the former Chief Business Development Officer for Fluence Bioengineering, a global leader in horticultural lighting solutions, he was responsible for creating and executing the business strategies that fueled Fluence’s rapid growth. In 2018, Fluence was acquired by German lighting technology group Osram Licht AG. In his concurrent role as Executive Chairman of Catalyst BC, Jerry has developed a deep understanding for the nuance of the industry and fostered relationships with top industry professionals across the entire cannabis ecosystem, from seed to sale.

Dr. Brian Toyota

MD, CM, MSc, FRCSC, Director

Dr. Toyota obtained his Medical Degree (MD) at McGill University, completed his neurosurgical residency at the University of Western Ontario and moved to B.C. in 1993. He began work at St. Paul’s Hospital before moving to Vancouver General Hospital (VGH) and the BC Cancer Agency (BBCA), in 1996. He was the Residency Program Director from 1995 – 2003; Co-Chair of the BCCA/Vancouver Stereotactic Radiosurgery Program from its inception in 1997 – 2013; Provincial Chair of Neuro-oncology for the BCCA 2004 – 2013 and President of the Canadian Neurosurgical Society 2012 – 2014. He is also on the editorial board of the Canadian Journal of Neurosciences and sits on the Royal College Specialty Committee for Neurosurgery and the Board of the American Association of Neurological Surgery.

Dr. Brian D. Toyota is a world-renowned medical and cancer expert, and the current Head of Neurosurgery at the University of British Columbia.

Dr. John Brunstein

Chief Scientific Officer

Dr. Brunstein obtained his Ph.D. in Biochemistry from the University of British Columbia in 1997, working on the molecular biology of viruses. Since then he has has worked with credible organizations including UBC as a Clinical Assistant Professor and later became the Chief Scientific Officer at the Centre for Translational and Applied Genomics. Dr. Brunstein has primarily worked through the company he founded, PathoID, as a consultant on biotechnology, molecular biology, and clinically related topics including clinical trials, assay validation methods, and quality systems in regulated industries for industrial and clinical sites in the US, Canada, and China. Dr. Brunstein has a broad exposure to biochemical analytical and molecular methods, quality systems, application of ISO/Health Canada/FDA and similar regulatory frameworks, and project management. His recognitions include the UBC Department of Pathology 2010 Faculty Award for Excellence in Research and Discovery, and he has an extensive publication record including a widely read monthly serialized article “The Primer” on aspects of clinical molecular diagnostics, now in its third year of publication in Medical Laboratory Observer.

Dr. Kevin She

BA, MSc., Ph.D., Quality Assurance Manager/Senior Scientist

Dr. She has a diverse background including industrial microbiology for the discovery of novel antibiotics, extensive expertise in mammalian tissue and cell culture, and industrial experience in writing and implementing SOPs for products intended for use in the clinical setting. During his grant funded industrial postdoctoral fellowship, Dr. She has written SOPs for the use, production, quality control, test validation, and real-time product stability testing for molecular diagnostic kits intended for use in the clinical setting. In addition to implementing these SOPs, he has also trained and supervised others in the adherence to these protocols. Throughout his career, Dr. She has acquired a strong academic publishing portfolio and contributed to successful C17 and NIH R01 grants, among others, and has personally been awarded MSFHR, a prestigious CIHR CGS, and NSERC grants.

Dr. Kevin Mehr

Ph.D., Vice-President of Sales

Having previously worked in business development and scientific advisory roles at Segra, Dr. Mehr now oversees sales of Segra’s diverse technological offerings. Dr. Mehr has been crucial in the establishment of key partnerships with leading licensed producers in the industry and continues to develop new business opportunities. Dr. Mehr received his Ph.D. in Genome Science and Technology from the University of British Columbia, and translates this experience with genetics and plant science to every facet of client management and product development.

Christine Thomson

Corporate Secretary

Ms. Thomson has 20 years of experience in the securities market including 12 years direct experience acting as an officer and or director providing corporate secretary services to listed companies. This experience includes working with highly active and successful companies listed on the TSX, TSX.V, NYSE and the Alternative Investment Market of the London Stock Exchange.

Ying Ng

Molecular Biology Lab Manager

Ms. Ng obtained her B.Sc. in Molecular Biology and Biochemistry from Simon Fraser University, followed by the Registered Technologist (CSMLS) program in Clinical Genetics from the British Columbia Institute of Technology. Working at BC Provincial Health Services Authority (PHSA) for over 12 years, she started as a clinical molecular and cytogenetics technologist. In 2011, she obtained formal certification in biobanking and led the biobanking efforts for the BC Cancer Agency and Vancouver General Hospital. In 2013 she completed her M.A. in Leadership from Trinity Western University. Most recently prior to joining Segra, her role in PHSA was as a lab manager where she oversaw facility planning of laboratory space, acquired capital equipment, and ensured proper resourcing of multiple projects.

Prabhleen Kaur

Senior Tissue Culture Specialist

Ms. Kaur is a highly technical and efficient tissue culture specialist who has studied under the tutelage of Dr. Zobayed for the past five years. She received her Diploma in Production Horticulture in 2015 from Kwantlen Polytechnic University. From there she achieved her Certification on Photoautotrophic Tissue Culture from the Faculty of Horticulture at Chiba University in Japan and Certification on Micropropagation Techniques from Nerang MDC in Australia. She began her career in 2011 as a Quality Control Technician at Lally Farms in Abbotsford, BC, and was then hired at JRT Nurseries, in Aldergrove, BC, as the Plant Tissue Culture Supervisor. She has held positions of increasing responsibility at JRT Nurseries, where she most recently held the position of Assistant Manager for the Tissue Culture Labs in Washington State and BC, that have a maximum output of 12 million plants a year for over 500 different plant species.

Vasyl Zaiets

PMP, MSc., Project Manager

Mr. Zaiets joined Segra in August of 2018 with extensive project management experience. He earned his Master’s Degree in Nuclear Engineering from the National Technical University of Ukraine, obtained his Business Management Diploma from BCIT, and currently holds a PMP designation. Prior to joining Segra, he was with ENCO involved in managing large-scale international projects related to nuclear safety and radioactive waste management.